South Korea to Track Zolpidem Prescriptions to Prevent Misuse

The South Korean Ministry of Food and Drug Safety (MFDS) added the insomnia medication Zolpidem to its medical narcotic prescription history verification system on the 19th. This measure enables doctors to check a patient’s medication history from the past year to prevent overdose and “doctor shopping” before prescribing the drug.

The MFDS established the verification system to stop patients from visiting multiple clinics to obtain excessive prescriptions. By reviewing a patient’s one-year history, physicians can determine if a new prescription would result in duplicate or excessive dosing, according to the ministry.

Did You Know? The MFDS verification system allows doctors to look back at a patient’s medical narcotic usage for exactly one year prior to a new prescription.

How does the Zolpidem tracking system prevent drug abuse?

The system targets “doctor shopping,” where individuals seek prescriptions from various providers to bypass dosage limits. By centralizing the medication history, the MFDS aims to create an environment where medical narcotics are used safely and appropriately.

According to the MFDS, this move is part of a phased rollout. The ministry previously made history verification mandatory for Fentanyl tablets and patches in 2024.

What are the known side effects and risks of Zolpidem?

Zolpidem is a hypnotic sedative used to treat insomnia, specifically difficulty falling asleep. It works by strengthening the action of GABA, an inhibitory neurotransmitter in the brain, to induce sleep quickly.

While the drug is widely used because its short duration of action reduces next-day drowsiness, the MFDS warns of other risks. Potential side effects include dizziness, memory loss, and abnormal behaviors during sleep.

The drug is classified as a psychotropic substance due to its potential for abuse and dependence. Long-term use or doses exceeding the prescription limit may lead to tolerance. Patients who stop the medication abruptly could experience anxiety or “rebound insomnia,” where sleeplessness worsens.

Expert Insight: Samantha Carter notes that while Zolpidem’s fast-acting nature makes it a primary choice for sleep onset issues, the transition to a mandatory tracking system highlights the tension between immediate clinical efficacy and long-term patient dependency risks.

Which other drugs are part of the MFDS expansion plan?

The ministry’s roadmap includes several other substances. In 2025, the MFDS plans to recommend prescription history checks for appetite suppressants and methylphenidate, a medication used to treat ADHD.

Future expansions may include Propofol and other medical narcotics that carry a high risk of misuse. The MFDS stated it will continue expanding the system to prevent the over-prescription of medical narcotics.

Frequently Asked Questions

What is the main goal of adding Zolpidem to the verification system?
The MFDS aims to prevent the misuse and overdose of Zolpidem by stopping “doctor shopping” and ensuring physicians can see a patient’s one-year prescription history.

How does Zolpidem help patients fall asleep?
According to the source, Zolpidem strengthens the action of GABA, an inhibitory neurotransmitter in the brain, to induce sleep relatively quickly.

Is Zolpidem considered an illegal drug?
No, it is not an illegal drug or a narcotic painkiller, but it is managed as a psychotropic drug because of its potential for dependence and abuse.

Do you believe tracking prescription histories is the most effective way to prevent medication misuse?